Edition:
United Kingdom

Petmed Express Inc (PETS.OQ)

PETS.OQ on NASDAQ Stock Exchange Global Select Market

45.69USD
20 Feb 2018
Change (% chg)

$1.52 (+3.44%)
Prev Close
$44.17
Open
$44.25
Day's High
$46.80
Day's Low
$44.25
Volume
206,227
Avg. Vol
232,248
52-wk High
$57.67
52-wk Low
$19.21

Chart for

About

PetMed Express, Inc. (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000... (more)

Overall

Beta: 1.07
Market Cap(Mil.): $734.75
Shares Outstanding(Mil.): 20.60
Dividend: 0.20
Yield (%): 2.24

Financials

  Industry Sector
P/E (TTM): -- 20.98 16.60
EPS (TTM): -- -- --
ROI: -- 11.72 10.66
ROE: -- 13.91 14.30

BRIEF-‍Plaintiffs Dismiss Shareholders Claims Dated August And September 2017

* PETMED EXPRESS - ‍PLAINTIFFS INVESTIGATED SHAREHOLDERS CLAIMS DATED AUGUST AND SEPT 2017, VOLUNTARILY DISMISSED CONSOLIDATED LAWSUIT - SEC FILING Source text for Eikon: [http://bit.ly/2Dyf1G6] Further company coverage:

23 Jan 2018

BRIEF-PetMed Express Reports Q3 EPS OF $0.44

* PETMED EXPRESS D/B/A 1-800-PETMEDS ANNOUNCES ITS THIRD QUARTER FINANCIAL RESULTS AND INCREASED ITS QUARTERLY DIVIDEND BY 25% TO $0.25 PER SHARE

22 Jan 2018

BRIEF-Petmed Express Q2 earnings per share $0.43

* Petmed Express D/B/A 1-800-petmeds announces record second quarter financial results

23 Oct 2017

PetMed CFO says allegations of marketing to opioid addicts are 'bogus'

SAN FRANCISCO A short seller's allegations that PetMed Express markets pet medicine to human opioid addicts are "bogus," PetMed Chief Financial Officer Bruce Rosenbloom told Reuters on Wednesday.

23 Aug 2017

PetMed CFO says allegations of marketing to opioid addicts are 'bogus'

SAN FRANCISCO, Aug 23 A short seller's allegations that PetMed Express markets pet medicine to human opioid addicts are "bogus," PetMed Chief Financial Officer Bruce Rosenbloom told Reuters on Wednesday.

23 Aug 2017

Competitors

  Price Chg
IDEXX Laboratories, Inc. (IDXX.OQ) $183.16 +0.68
Heska Corp (HSKA.OQ) $59.71 -1.34

Earnings vs. Estimates